发明名称 |
METHOD OF TREATING SKELETAL DYSPLASIAS USING VESSEL DILATOR |
摘要 |
C-natriuretic peptide (CNP) has been shown to regulate proliferation of mouse and rat osteoblasts. Genetic deletion of CNP results in dwarfism. CNP effects on bone growth involve inhibition of MEK 1 and ERK 1/2 kinases mediated via the intracellular messenger cyclic GMP. Vessel dilator is another natriuretic peptide synthesized by the atrial natriuretic peptide gene whose biologic half-life is 12 times longer than CNP. Vessel dilator's biologic effects on proliferating cells are mediated via inhibiting MEK 1/2 and ERK 1/2 kinases via cyclic GMP. Vessel dilator was not studied previously on osteoblasts. CNP and vessel dilator were tested in dose-response studies enhanced human osteoblasts' proliferation, showing that vessel dilator has identical mechanisms of action to CNP but much longer biologic half-life and effects at lower concentrations. Vessel dilator exhibited therapeutic effect for use in human achondroplasia, short stature and osteoporosis by stimulating osteoblast proliferation. |
申请公布号 |
WO2011153531(A1) |
申请公布日期 |
2011.12.08 |
申请号 |
WO2011US39277 |
申请日期 |
2011.06.06 |
申请人 |
UNIVERSITY OF SOUTH FLORIDA;UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;VESELY, DAVID, LYNN |
发明人 |
VESELY, DAVID, LYNN |
分类号 |
A61K38/22;C07K14/58 |
主分类号 |
A61K38/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|